Benefit from anthracyclines in relation to biological profiles in early breast cancer
Benefit from anthracyclines in relation to biological profiles in early breast cancer
About this item
Full title
Author / Creator
Rocca, Andrea , Bravaccini, Sara , Scarpi, Emanuela , Mangia, Anita , Petroni, Stella , Puccetti, Maurizio , Medri, Laura , Serra, Luigi , Ricci, Monica , Cerasoli, Serenella , Biglia, Nicoletta , Maltoni, Roberta , Giunchi, Donata Casadei , Gianni, Lorenzo , Tienghi, Amelia , Brandi, Mario , Faedi, Monica , Sismondi, Piero , Paradiso, Angelo , Silvestrini, Rosella and Amadori, Dino
Publisher
Boston: Springer US
Journal title
Language
English
Formats
Publication information
Publisher
Boston: Springer US
Subjects
More information
Scope and Contents
Contents
There are no validated predictors of benefit from anthracyclines. We compared cyclophosphamide, methotrexate, 5-fluorouracil (CMF), and epirubicin in different sequences with CMF alone in a phase III trial on operable breast cancers. Outcomes were analyzed in relation to tumor biological profiles to identify potential predictors of the efficacy of...
Alternative Titles
Full title
Benefit from anthracyclines in relation to biological profiles in early breast cancer
Authors, Artists and Contributors
Author / Creator
Bravaccini, Sara
Scarpi, Emanuela
Mangia, Anita
Petroni, Stella
Puccetti, Maurizio
Medri, Laura
Serra, Luigi
Ricci, Monica
Cerasoli, Serenella
Biglia, Nicoletta
Maltoni, Roberta
Giunchi, Donata Casadei
Gianni, Lorenzo
Tienghi, Amelia
Brandi, Mario
Faedi, Monica
Sismondi, Piero
Paradiso, Angelo
Silvestrini, Rosella
Amadori, Dino
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1506795921
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1506795921
Other Identifiers
ISSN
0167-6806
E-ISSN
1573-7217
DOI
10.1007/s10549-013-2819-0
